GIBU
RVMD icon

Gulf International Bank (UK)’s Revolution Medicines RVMD Stock Holding History

Gulf International Bank (UK)’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69M Buy
14,362
+3,239
+29% +$473K 0.05% 310
2026
Q1 		$1.08M Buy
+11,123
New +$1.12M 0.02% 495

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Gulf International Bank (UK)'s RVMD Position: Q2 2026 in Review

Gulf International Bank (UK) increased its Revolution Medicines (RVMD) stake by 29% in Q2 2026, buying an estimated $473K and bringing the position to 14,362 shares worth $2.69M. The position accounts for 0.05% of the portfolio, ranked #310.

Gulf International Bank (UK) first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Gulf International Bank (UK) held 14,362 shares of Revolution Medicines worth $2.69M as of Q2 2026.
  • Gulf International Bank (UK) bought 3,239 Revolution Medicines shares in Q2 2026, an estimated $473K.
  • Revolution Medicines made up 0.05% of Gulf International Bank (UK)'s portfolio in Q2 2026, its #310 holding.
  • Gulf International Bank (UK) first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Gulf International Bank (UK)'s 13F filing for Q2 2026, filed 13 Aug 2026.